Costly GLP-1 drug use for weight loss has soared, study reports
The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...
Fractyl Health Reports Positive Early Data Showing Revita® Has Potential to Prevent Weight Regain After GLP-1 Discontinuation
New REVEAL-1 study results show early signs of weight maintenance after GLP-1 discontinuationREMAIN-1 pivotal study now more than 50% enrolled; ...
EurekAlert!8d
Weight-loss drug use has risen sharply among children and adults with type 1 diabetes
Popular prescription weight-loss drugs called GLP-1 receptor agonists are now frequently used by type 1 diabetes patients, despite limited data on the drugs’ safety and effectiveness in this patient ...
Where Will Eli Lilly Be in 1 Year?
Lately, however, Eli Lilly's stock has cooled. Shares have been essentially flat since July 2024. The market for GLP-1 ...
Seeking Alpha13d
Allurion surges on weight loss data from gastric balloon, GLP-1 combo treatment
surged ~31% in after-hours trading Thursday after posting preliminary data on weight loss associated with its gastric balloon in combination with Novo Nordisk's (NVO) GLP-1 semaglutide.
Healthcare Dive9d
GLP-1s are accelerating spending growth on traditional drugs, Evernorth research finds
Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...
The Star5d
The GLP-1 workout: Targeting the muscle loss from taking these drugs
The class of drugs – GLP-1 receptor agonists – has been around for two decades as a diabetes medication. Their popularity as a tool for weight loss skyrocketed after the US Food and Drug ...